Although clear patterns of avelumab treatment-related changes within the papilloma samples were absent, papilloma samples generally displayed gene expression indicative of low dendritic cell and CD8 T-cell infiltration but increased myeloid cell inflammation and transforming growth factor-β (TGFβ) expression, compared to normal mucosa. The gene discussed is TGFB1; the disease is papilloma.